Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000175

Drug Information
NameNicotine
Synonyms1uw6; 46343_FLUKA; beta-Pyridyl-alpha-N-methyl pyrrolidine; (-)-Nicotine; MLS001335905; PDSP1_000465; SAM002564224; LS-202; PDSP2_000555; ENT 3,424; Nikotin [German]; nicotine; Nikotyna [Polish]; N5511_FLUKA; Nicotine (compounds related to); NCGC00090693-03; (-)-Nicotine solution; AC1L3I79; MLS001055457; NCGC00090693-06; CHEBI:17688; Nicotine [UN1654] [Poison]; Caswell No. 597; EPA Pesticide Chemical Code 056702; Nicotine (USP); 36733_RIEDEL; 36733_FLUKA; 3-(N-Methylpyrrolidino)pyridine; Nicotina [Italian]; NCGC00090693-02; (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine; (S)-Nicotine; 434F7990-3240-4A43-ACEC-E6CC1E495FA0; Habitrol (TN); NCT; EINECS 200-193-3; NCGC00090693-05; CID89594; SDCCGMLS-0066911.P001; CPD000059074; bmse000105; L(-)-nicotine; CCRIS 1637; Nicoderm Patch; (S)-3-(1-methylpyrrolidin-2-yl)pyridine; PDSP2_000463; Nicotine [BSI:ISO]; 3-(2-(N-methylpyrrolidinyl))pyridine; (S)-3-(N-methylpyrrolidin-2-yl)pyridine; RCRA waste number P075; (−)-Nicotine; N3876_SIGMA; BIDD:GT0599; (−)-1-Methyl-2-(3-pyridyl)pyrrolidine; 46343_RIEDEL; 54-11-5; NCGC00090693-01; Nictoine patch; (S)-(-)-Nicotine; BRD-K05395900-322-02-1; Nicotine Patch; MolPort-000-744-731; BB_NC-0777; Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)-; CHEMBL3; AC1Q3ZOC; SMR000059074; D03365; NSC97238; PDSP1_000113; 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine; C00745; NSC 5065; AI3-03424; NICOTINE AND SALTS; NCGC00090693-04; (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE; N5511_SIGMA; Micotine; 3-(N-Methylpyrollidino)pyridine; Nicotine [USAN]; (−)-Nicotine solution; Habitrol; RCRA waste no. P075; UN1654; HSDB 1107; NCGC00090693-07; nicotine replacement patch; Transdermal Nicotine
Trade NameNicorette
CompanyUpjohn Corporation
IndicationNicotine dependence
[ICD9: 305.1   ICD10: F17]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2
,1H3/t10-/m0/s1
InChIKeySNICXCGAKADSCV-JTQLQIEISA-N
Canonical SMILESCN1CCCC1C2=CN=CC=C2    
Isomeric SMILESCN1CCC[C@H]1C2=CN=CC=C2
Therapeutic ClassCentral Nervous System Agents
CAS NumberCAS 54-11-5
FormulaC10H14N2
PubChem Compound IDCID 89594.
PubChem Substance IDSID 4007.
ChEBI17688;
SuperDrug ATC IDN07BA01
SuperDrug CAS ID000054115;
TargetNicotinic acetylcholine receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074611 To Reference
Ref 2Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. Neuropharmacology. 2009 Aug;57(2):183-91. Epub 2009 May 28. To Reference
Ref 3Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptors. J Neurosci Methods. 2009 Aug 30;182(1):17-24. Epub 2009 May 27. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543